Compare Enveric Biosciences Inc (ENVB) vs Invesco S&P 500 High Div Low Volatility ETF (SPHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Invesco S&P 500 High Div Low Volatility ETF — how do they compare? Enveric Biosciences Inc trades at $1.4 (market cap $5.32M), while Invesco S&P 500 High Div Low Volatility ETF trades at $53.16. The key difference: Invesco S&P 500 High Div Low Volatility ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | SPHD | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | — |
52-Week High | $17.40 | $52.63 |
52-Week Low | $1.28 | $46.96 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
The Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) trades at $53.06, up 2.08% on the day, with a bullish technical signal from moving averages and neutral oscillators. The fund provides monthly dividend income with a 4.5% 30-day SEC yield, targeting high-dividend, low-volatility S&P 500 stocks. Recent news highlights its role in retirement income portfolios, though historical returns have lagged the broader S&P 500.
SPHD offers defensive income exposure suitable for risk-averse investors, with a portfolio tilted toward real estate, consumer staples, and financials. Key risks include underperformance during strong bull markets and concentration in value sectors. The fund's consistent monthly payout and low-volatility mandate provide stability, but growth-oriented investors may find total returns insufficient.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →
